Literature DB >> 35639418

FOXM1 Promotes Malignant Proliferation of Esophageal Squamous Cell Carcinoma Through Transcriptional Activating CDC6.

Xiongfeng Chen1, Jingbo Chen2, Xunbin Yu3, Guishan Lin2, Ting Chen1,4.   

Abstract

Forkhead box M1 (FOXM1) is a proliferative transcription factor and plays a vital role in many cancers. However, the function and molecular mechanism of FOXM1 in esophageal squamous cell carcinoma (ESCC) remain poorly understood. Hence, we aim to clarify the molecular basis of FOXM1-mediated ESCC progression. In this study, bioinformatics analysis showed that FOXM1 was mainly involved in key signal pathways, including cell proliferation, cell cycle, and homologous recombination in ESCC, and predicted that CDC6 might be a potential regulatory target gene of FOXM1. The results revealed that FOXM1 and CDC6 were significantly overexpressed in ESCC tissue and cell line, and their expression was positively correlated. Further studies showed that FOXM1 directly transcriptionally activated CDC6 by binding to its promoter region in ESCC cells. Moreover, FOXM1 mediated ESCC cell proliferation by regulating CDC6 expression, which may be related to promoting G1-S phase transition of cell cycle. Taken together, FOXM1-CDC6 axis mediates ESCC malignant proliferation and may serve as a potential biological target for ESCC treatment.

Entities:  

Keywords:  CDC6; FOXM1; esophageal squamous cell carcinoma; tumor proliferation

Mesh:

Substances:

Year:  2022        PMID: 35639418      PMCID: PMC9293688          DOI: 10.1089/dna.2022.0169

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.550


  30 in total

1.  Single-molecule studies of origin licensing reveal mechanisms ensuring bidirectional helicase loading.

Authors:  Simina Ticau; Larry J Friedman; Nikola A Ivica; Jeff Gelles; Stephen P Bell
Journal:  Cell       Date:  2015-04-16       Impact factor: 41.582

2.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

Review 3.  FOXM1: a potential therapeutic target in human solid cancers.

Authors:  Soheila Borhani; Andrei L Gartel
Journal:  Expert Opin Ther Targets       Date:  2020-02-19       Impact factor: 6.902

4.  FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.

Authors:  Vladimir Petrovic; Robert H Costa; Lester F Lau; Pradip Raychaudhuri; Angela L Tyner
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

Review 5.  FoxM1: Repurposing an oncogene as a biomarker.

Authors:  Deeptashree Nandi; Pradeep Singh Cheema; Neha Jaiswal; Alo Nag
Journal:  Semin Cancer Biol       Date:  2017-09-10       Impact factor: 15.707

6.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt.

Authors:  Steffen Durinck; Paul T Spellman; Ewan Birney; Wolfgang Huber
Journal:  Nat Protoc       Date:  2009-07-23       Impact factor: 13.491

7.  Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds.

Authors:  Yvonne Ziegler; Mary J Laws; Valeria Sanabria Guillen; Sung Hoon Kim; Parama Dey; Brandi P Smith; Ping Gong; Noah Bindman; Yuechao Zhao; Kathryn Carlson; Mayuri A Yasuda; Divya Singh; Zhong Li; Dorraya El-Ashry; Zeynep Madak-Erdogan; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  NPJ Breast Cancer       Date:  2019-11-29

8.  SUMOylation inhibits FOXM1 activity and delays mitotic transition.

Authors:  S S Myatt; M Kongsema; C W-Y Man; D J Kelly; A R Gomes; P Khongkow; U Karunarathna; S Zona; J K Langer; C W Dunsby; R C Coombes; P M French; J J Brosens; E W-F Lam
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

Review 9.  Regulation of the master regulator FOXM1 in cancer.

Authors:  Guo-Bin Liao; Xin-Zhe Li; Shuo Zeng; Cheng Liu; Shi-Ming Yang; Li Yang; Chang-Jiang Hu; Jian-Ying Bai
Journal:  Cell Commun Signal       Date:  2018-09-12       Impact factor: 5.712

10.  Maternal Embryonic Leucine Zipper Kinase Promotes Tumor Growth and Metastasis via Stimulating FOXM1 Signaling in Esophageal Squamous Cell Carcinoma.

Authors:  Liang Chen; Qiuren Wei; Shuning Bi; Songqiang Xie
Journal:  Front Oncol       Date:  2020-01-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.